Uploaded April 2018 | Updated September 2026, 2 weeks ago
There are 500 million people around the world suffering from type 2 diabetes. From monitoring blood sugar to taking insulin, diabetic patients are forced to take on a huge responsibility in managing their health. Fractyl, led by Co-Founder and CEO Harith Rajagopalan, has set out to change the way we treat Type 2 diabetes patients—by shifting the focus from the pancreas to the gut. Watch Harith’s 2017 TEDMED Hive Talk to learn more about how Fractyl’s minimally invasive devices and clinical procedures could help to reduce the massive physical and financial burdens of diabetes management that we face on both individual and societal levels.
There are 500 million people around the world suffering from type 2 diabetes. From monitoring blood sugar to taking insulin, diabetic patients are forced to take on a huge responsibility in managing their health. Fractyl, led by Co-Founder and CEO Harith Rajagopalan, has set out to change the way we treat Type 2 diabetes patients—by shifting the focus from the pancreas to the gut. Watch Harith’s 2017 TEDMED Hive Talk to learn more about how Fractyl’s minimally invasive devices and clinical procedures could help to reduce the massive physical and financial burdens of diabetes management that we face on both individual and societal levels.
